Acknowledges that newly authorised vaccines are untested
Monday, Sept 28, 2009
The British Government has officially stated that it has no plans to implement a mandatory H1N1 mass vaccination program, despite previous statements intimating that it will, and despite the fact that its pandemic response planning is based on such a premise.
A portion of a statement from the Government on the number10.gov.uk website  reads:
“No decision has been taken to embark on a mass vaccination campaign, but any vaccination against swine flu would not be compulsory. Everyone has a right to refuse the swine flu vaccination, or any other vaccination. Where a child is too young to consent themselves to being vaccinated, the right to decide rests with the person with parental responsibility.”
Health authorities have previously said they plan to have 60 million plus UK citizens vaccinated by next Summer (almost the entire population), despite the fact that only a handful of people have died from swine flu in Britain.
We have previously highlighted how regional H1N1 pandemic planning documents for the UK indicate that local authorities, in conjunction with other departmentalized agencies,
intend to set up mass vaccination sites  to be overseen by crowd control police.
One of the documents highlights a need to keep the location of mass vaccination centres secret from the public , while another lists a sports stadium as a location for mass public inoculation.
- A d v e r t i s e m e n t
A sample vaccination order  (PDF) originating from the NHS health authority in Bolton, Lancashire, states that people in the UK will be summoned for a vaccination at an “allocated” date and time at pre-planned mass vaccination centres, and that refusal to attend is not an option.
The fear of a planned mandatory nationwide roll out of the swine flu vaccine has prompted mass opposition  in the UK.
The denial of a mandatory vaccination program comes in the form of a response to a petition to 10 Downing Street against the use of a swine flu virus as a bioweapon.
The Government’s response also states:
“The European Medicines Agency (EMA) has strict processes in place for licensing pandemic vaccines.”
However, the EMEA, which is heavily funded by the pharmaceutical industry, has recently granted marketing authorisation to two swine flu vaccines in spite of the fact the vaccines have not been tested.
Focetria produced by Novartis and Pandemrix produced by GlaxoSmithKline, which contains both squalene and thiomersal and is classified by the EU as a bioweapon, were authorised last week, and are likely to be authorised for use by the European Commission shortly.
“There is currently no clinical experience with Focetria (H1N1) in adults, including the elderly, children or adolescents,” notes the EMEA on its pandemic influenza H1N1 website. 
In addition, EMEA also states on its pandemic website  that there is “no clinical experience in the elderly, in children or in adolescents” with pandemrix.
“There is currently very limited clinical experience with an investigational formulation of Pandemrix (H1N1) containing a higher amount of antigen (see section 5.1) in healthy adults aged 18-60 years and no clinical experience in the elderly, in children or in adolescents.” the site notes.
Authorisation was given for the two vaccines based on research using “mock up” bird flu vaccines dating from 2007 and 2008, according to the EMEA.
The British Government’s statement also acknowledges this as it reads:
“In preparing for a pandemic, appropriate trials to assess safety and the immune responses have been carried out on vaccines very similar to the swine flu vaccine. The vaccines have been shown to have a good safety profile.”
The UK Government has intimate links with the makers of the Pandemrix vaccine, given that one its top advisors on swine flu also happens to be a sitting board member of GlaxoSmithKline .
Due to the fact that the vaccines are untested, the U.S. government is establishing an extensive tracking system to watch for possible side effects .
According to the New York Times , this involves “responding rapidly” to news stories linking the vaccines to heart attacks, strokes, seizures, spontaneous miscarriages and Guillain-Barré syndrome.
The move mirrors that of the British government, which sent a confidential letter to senior neurologists  last month telling them to be on the alert for cases of Guillain-Barré syndrome, which could be triggered by the vaccine.
The news comes as the promised “second wave” of swine flu  has been announced in the U.S.